Improving quality of life in chronic lymphocytic leukemia.

about

Impact of novel agents on patient-relevant outcomes in patients with previously untreated chronic lymphocytic leukemia who are not eligible for fludarabine-based therapy.

P2860

Q38673560-891AFE40-A970-4F22-B9E1-B735D001B5D5

P2860

Improving quality of life in chronic lymphocytic leukemia.

Item

http://www.wikidata.org/entity/Q48497471

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Improving quality of life in chronic lymphocytic leukemia.

@en

Improving quality of life in chronic lymphocytic leukemia.

@nl

type

Item

label

Improving quality of life in chronic lymphocytic leukemia.

@en

Improving quality of life in chronic lymphocytic leukemia.

@nl

prefLabel

Improving quality of life in chronic lymphocytic leukemia.

@en

Improving quality of life in chronic lymphocytic leukemia.

@nl

P1476

Improving quality of life in chronic lymphocytic leukemia.

@en

P2093

Clive S Zent

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

Combination chemoimmunotherapy with pentostatin, cyclophosphamide, and rituximab shows significant clinical activity with low accompanying toxicity in previously untreated B chronic lymphocytic leukemia

Quality of life in chronic lymphocytic leukemia: a neglected issue.

Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial.

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial.

Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia.

Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia.

Quality of life in chronic lymphocytic leukemia: 5-year results from the multicenter randomized LRF CLL4 trial.

Patients' experience of chronic lymphocytic leukaemia: baseline health-related quality of life results from the LRF CLL4 trial.

P304

1247-1248

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10428194.2012.656106

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221745386

http://www.w3.org/2001/XMLSchema#string

P698

22242823

http://www.w3.org/2001/XMLSchema#string

P921

quality of life

lymphocyte

Improving quality of life in chronic lymphocytic leukemia.

about

P2860

P2860

Improving quality of life in chronic lymphocytic leukemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921